Advertisement

Topics

Latest "The American Society for Cell Biology" News Stories

07:14 EDT 24th September 2018 | BioPortfolio

Here are the most relevant search results for "The American Society for Cell Biology" found in our extensive news archives from over 250 global news sources.

More Information about The American Society for Cell Biology on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about The American Society for Cell Biology for you to read. Along with our medical data and news we also list The American Society for Cell Biology Clinical Trials, which are updated daily. BioPortfolio also has a large database of The American Society for Cell Biology Companies for you to search.

Showing "American Society Cell Biology" News Articles 1–25 of 17,000+

Monday 24th September 2018

FARXIGA Achieved a Positive Result in the Phase III DECLARE-TIMI 58 Trial, a Large Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes

FARXIGA met the primary composite endpoint of a statistically-significant reduction in hospitalization for heart failure or CV death in a broad patient population Results confirmed the well-established safety profile of FARXIGA AstraZeneca today announced positive results from the Phase III DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (C...


ArQule to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology on October 2, 2018

ArQule, Inc. (Nasdaq:ARQL) today announced that Peter Lawrence, President and Chief Operating Officer, Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, and Marc Schegerin, Senior Vice President, Strategy, Communication and Finance, will present at the Leerink Partners Roundtable Series on October 2, 2018, at 8:00am ET at the ...

ArQule to Present at the Cantor Global Healthcare Conference on October 1, 2018

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Marc Schegerin, Senior Vice President, Strategy, Communication and Finance, will present at the Cantor Global Healthcare Conference on October 1, 2018, at 2:55pm ET at the InterContinental New York Barclay Hotel in New York City. The live webcast of the pres...


AmpliPhi Biosciences to Present Clinical Case Series Data at IDWeek 2018

Professor Jonathan Iredell to present data from AmpliPhi Biosciences’ ongoing expanded access program for bacteriophage product candidates AB-SA01 (targeting S. aureus) and AB-PA01 (targeting P. aeruginosa) AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targete...

Biofrontera AG: Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference

DGAP-News: Biofrontera AG / Key word(s): Conference 24.09.2018 / 10:38 The issuer is solely responsible for the content of this announcement. Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference Leverkusen, Germany, September 24, 2018 - Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that ...

Epizyme Announces the U.S. Food and Drug Administration Lifts Partial Clinical Hold on Tazemetostat Clinical Program

Investor Conference Call Scheduled for Today at 8:30 a.m. EDT Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage company developing novel epigenetic therapies, today announced the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold that had paused U.S.-based enrollment of new patients in its tazemetostat clinical tr...

New Case Study - Cell Culture Applications for Cell Biology

Understanding the process of interaction between healthy and diseased cells provides a better understanding of the life processes of organisms, resulting in more effective medicines, new vaccines. In every successful relationship, communication is key. This can be among friends in a social setting, at home with family or in the workplace with colleagues....

BVGH’s African Access Initiative Featured at Biden Cancer Summit

BIO Ventures for Global Health (BVGH) was featured at last week’s Biden Cancer Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, for its commitment to addressing Africa’s long under-recognized

Attorney Stephanie A. Bogue joins Gilmore & Bell

Gilmore & Bell, P.C., a leading public finance law firm, is pleased to announce that Stephanie A. Bogue has joined the Firm as an associate attorney in the St. Louis office. Stephanie was admitted to the Missouri Bar in 2018 after graduating from the Saint Louis University School of Law (magna cum laude). During law school, Ms. Bogue won six A...

American Parkinson Disease Association Launches Parkinson’s Training for Fitness, Health and Wellness Professionals

Free online training program designed to teach fitness professionals how to best meet the unique needs of people with Parkinson’s disease NEW YORK (PRWEB) September 24, 2018 The American Parkinson Disease Association (APDA) launches today a brand new, highly-specialized training program for fitness, health and wellness professionals to help make exercise more available and approachable for peop...

EDETEK Kicks Off Fall with Two Major Life Sciences Industry Events

Company addressing full data lifecycle with disruptive solutions PRINCETON, N.J. (PRWEB) September 24, 2018 EDETEK, the premier provider of digital clinical trial platforms, today announced that the team will be exhibiting at the Society for Clinical Data Management (SCDM) 2018 Annual Conference taking place in Seattle, WA on September 23-26, 2018. The team will also be participating at DPHARM: D...

Scotland makes its mark in mammalian synthetic biology

This story is brought to you by our sponsor SynbiCITE, which is accelerating the commercialization of synthetic biology applications. To learn how SynbiCITE is nucleating a sustainable UK economy, visit www.synbicite.com. Perhaps better known for its International Festival, dramatic castle […] The post Scotland makes its mark in mammalian synthetic biology appeared first on SynBioBeta.

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

• First-to-market cell line-derived reference standard for myeloid blood cancers • Largest cell-line derived reference standard available, contains 22 mutations across 19 oncology-relevant genes • Enables faster, more reliable and more cost-effective assay validation Cambridge, UK, 24 September, 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “t...

Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid

F. Hoffmann-La Roche Ltd / Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Liquid biopsy test can identify 70 of the most commonly mutated genes in solid tumours, as well as microsatellite instability Many can...

Global AntiViral Therapeutics Market Segmented by Drug Type, Distribution Channel Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global antiviral Therapeutics market is expected to register a CAGR of 6.2% during the forecast period, 2018 to 2023. North America dominates the market due to growing prevalence of Hepatitis C HIV infections, coupled with the presence of huge patient pool suffering from virally infectious diseases.High Prevalence of Different Viral InfectionAccording to the World Health Organization WHO, it ...

Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company’s Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer

– FoundationOne Liquid analyzes 70 genes known to drive cancer growth and reports microsatellite instability high (MSI-high) status to inform the use of precision oncology treatments, including immunotherapies, with a simple blood draw – Foundation Medicine, Inc. today announced that FoundationOne®Liquid, its next-generation liquid biopsy t...

MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate

Preclinical studies of lead molecules have shown absence of respiratory depression, rewarding behavior, sedation, and constipation associated with traditional opioids MEBIAS Discovery, an emerging leader in the field of drug discovery targeting G-protein coupled receptors, has secured grant funding from the National Institute of Drug Abuse (NIDA) to pr...

Sunday 23rd September 2018

AGA partners with ESNM for 2019 Gut Microbiota for Health World Summit

The American Gastroenterological Association is proud to partner with the European Society of Neurogastroenterology and Motility for the 8th annual Gut Microbiota for Health World Summit.

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

A research team led by Arun Iyer, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences at Wayne State University, has developed a nanoplatform technology that works in combination with existing chemotherapeutic drugs that may reverse drug-resistance in renal cell carcinoma.

Phase Holographic Imaging AB Medical Equipment Deals and Alliances Profile [Report Updated: 18072018] Prices from USD $250

SummaryPhase Holographic Imaging AB PHI is a medical device company that develops timelapse cytometry instrumentation and software. The company's products include HoloMonitor M4 and demo software. Its HoloMonitor timelapse cytometers provides cellular behavior to be continuously quantified and monitored. PHI's products are used in various applications such as cell cycle, toxicology, cell motility,...

#jobs #lifescience Wellcome Sanger Institute: Postdoctoral Fellow – Computational Biology (Haematological Cancer Genetics)

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Wellcome Sanger Institute: Postdoctoral Fellow – Computational Biology (Haematological Cancer Genetics) . Apply now on-line View Job Details Send to a friend: Wellcome Sanger Institute: Job Reference 83218 … Continue reading → Cet article #jobs #

Bone Therapeutics to present at 26th Annual Meeting of the European Orthopaedic Research Society

Press release Gosselies, Belgium, 24 September 2018, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces that the Company will present on 26 September at the 26th Annual Meeting of the European Orthopaedic Research Society (EORS), in Galway, Ireland. ...

Antimalarial drug boosted with chemo medicines

Scientists from The University of Melbourne have found a way to boost the efficacy of the world’s most powerful antimalarial drug with the help of chemotherapy medicines, in a breakthrough that may hold the key to overcoming antimalarial drug resistance. Malaria claims the lives of about 450,000 people worldwide every year. Resistance to antimalarial drug artemisinin has already developed in So...

The taller you are, the more likely you may develop varicose veins

(American Heart Association) A person's height may be a risk factor for varicose veins, which can be associated with other health risks. Genes that predict a person's height may be at the root of this association between height and varicose veins and may provide clues for treating the condition.

Athersys to Present at 2018 Cell & Gene Meeting on the Mesa

CEO invited to provide corporate overview and speak in two workshops focusing on innovative development initiatives in Japan and advanced manufacturing technologies CLEVELAND, Ohio, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present at the annual Cell & Gene Meeting on the Mesa to be held October 3rd-5th i...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks